PD-L1 Protein, Mouse (HEK293, His)
Based on 3 publication(s) in Google Scholar
PD-L1 Protein is an important immunoregulatory molecule and a member of the B7 superfamily. As the primary ligand of PD-1, PD-L1 Protein can bind to PD-1 to inhibit T-cell activation, proliferation, and cytokine secretion, and induce T-cell apoptosis. PD-L1 Protein plays a key role in tumor immune escape and immune homeostasis regulation. PD-L1 Protein, Mouse (HEK293, His) is a recombinant PD-L1 protein expressed by HEK293 cells, with a C-6*His tag and glycosylation modification.
- Species: Mouse
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
PD-L1 Protein is an important immunoregulatory molecule and a member of the B7 superfamily. As the primary ligand of PD-1, PD-L1 Protein can bind to PD-1 to inhibit T-cell activation, proliferation, and cytokine secretion, and induce T-cell apoptosis. PD-L1 Protein plays a key role in tumor immune escape and immune homeostasis regulation. PD-L1 Protein, Mouse (HEK293, His) is a recombinant PD-L1 protein expressed by HEK293 cells, with a C-6*His tag and glycosylation modification[1][2].
Background
PD-L1 is a 33 kDa type I transmembrane glycoprotein containing 290 amino acids, with Ig- and IgC domains in its extracellular region. Under normal conditions, PD-L1 maintains immune homeostasis by binding to PD-1 on the surface of T cells to inhibit excessive immune responses. In tumors, abnormally high expression of PD-L1 binds to PD-1 to suppress T cell function, thereby helping tumors evade immune surveillance. PD-L1 may also be involved in tumor angiogenesis and microenvironmental remodeling. Currently, as a core target, PD-L1 has driven the development of tumor immune checkpoint inhibitor therapy[1][2].
Verified Bioactivity
1. Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated CTLL-2 mouse cytotoxic T cells. The ED50 this effect is <1.0 μg/mL.
2. Measured by its binding ability in a functional ELISA. Immobilized Mouse PD-L1 at 25 ng/mL (100μL/well) can bind Biotinylated Mouse PD-1. The ED50 for this effect is < 50 ng/mL.
MCE Validation Data
-
Purity - SDS-PAGE
Purity - SDS-PAGE
-
Bioactivity - Cell-Based Assay
Bioactivity - Cell-Based Assay
-
Bioactivity - ELISA
Bioactivity - ELISA
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
-
J Control Release
Multifunctional nanoparticles for immune regulation and oxidative stress alleviation in myocarditis. [Abstract]2025 May 10:381:113607. PMID: 40054631
PD-L1 Protein, Mouse (HEK293, His) purchased from MedChemExpress. Usage Cited in: J Control Release. 2025 May 10:381:113607. [Abstract]
PD-L1 Protein, Mouse (HEK293, His) (50 μg; i.v.; every 2 days) effectively suppressed cardiac inflammation and the release of pro-inflammatory cytokines in myocarditis mice.
-
J Med Chem
Discovery of Novel Proteolysis-Targeting Chimera Molecules as Degraders of Programmed Cell Death-Ligand 1 for Breast Cancer Therapy. [Abstract]2024 Jul 11;67(13):10589-10600. PMID: 38889052
Technical Parameters
-
Species Mouse
-
Source HEK293
-
Tag C-6*His
-
Accession
Q9EP73 (F19-T238)
-
Molecular Construction
-
N-term
-
PD-L1 (F19-T238)
Accession # Q9EP73 -
6*His
-
C-term
-
-
Protein Length
Extracellular Domain
-
Synonyms
CD274; B7 Homolog 1; Prev. PDCD1LG1; B7-H; PD-L1; PDCD1 Ligand 1; B7H1; PDCD1L1; PDL1; HPD-L1; Programmed Cell Death 1 Ligand 1; Programmed Death Ligand 1; CD274 Antigen; ADMIO5; CD274 Molecule; B7-H1
-
AA Sequence
FTITAPKDLYVVEYGSNVTMECRFPVERELDLLALVVYWEKEDEQVIQFVAGEEDLKPQHSNFRGRASLPKDQLLKGNAALQITDVKLQDAGVYCCIISYGGADYKRITLKVNAPYRKINQRISVDPATSEHELICQAEGYPEAEVIWTNSDHQPVSGKRSVTTSRTEGMLLNVTSSLRVNATANDVFYCTFWRSQPGQNHTAELIIPELPATHPPQNRT
-
Molecular Weight
Approximately 39-58 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Glycosylation
Yes
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder
1.Lyophilized from a 0.22 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.4.
2.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 8% trehalose.
Please refer to the lot-specific COA for specific buffer information.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (262 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)